54868-5240 : Exelon 4.5 mg Oral Capsule


NDC: 54868-5240
Labeler: Physicians Total Care, Inc.
Product Type: Human Prescription Drug
Drug Name:  Exelon
Dosage Form: Oral Capsule
Application #: NDA020823
Rev. Date: 


Appearance:


Markings: Exelon;4;5mg
Shapes:  Capsule
Colors:  Red
Size (mm): 1
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 54868-5240-0: 30 CAPSULE IN 1 BOTTLE (54868‑5240‑0)

Active Ingredients:

  • Rivastigmine Tartrate

Dosage Strength:

  • 4.5 mg

Inactive Ingredients:

  • Gelatin
  • Hypromellose
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Ferric Oxide Red
  • Silicon Dioxide
  • Titanium Dioxide
  • Ferric Oxide Yellow

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 54868-4512 Exelon 1.5 mg Oral Capsule by Physicians Total Care, Inc.
  • 54868-5339 Exelon 6 mg Oral Capsule by Physicians Total Care, Inc.
  • 54868-5839 Exelon 3 mg Oral Capsule by Physicians Total Care, Inc.
  • 54868-5954 Exelon 9.5 mg/24[usp'u] Transdermal Patch, Extended Release by Physicians Total Care, Inc.
  • 54868-6070 Exelon 4.6 mg/24[usp'u] Transdermal Patch, Extended Release by Physicians Total Care, Inc.
  • 0078-0323 Exelon 1.5 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0324 Exelon 3 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0325 Exelon 4.5 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0326 Exelon 6 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0339 Exelon 2 mg/ml Oral Solution by Novartis Pharmaceuticals Corporation
  • 0078-0501 Exelon 4.6 mg/24h Transdermal Patch, Extended Release by Novartis Pharmaceuticals Corporation
  • 0078-0502 Exelon 9.5 mg/24h Transdermal Patch, Extended Release by Novartis Pharmaceuticals Corporation
  • 0078-0503 Exelon 13.3 mg/24h Transdermal Patch, Extended Release by Novartis Pharmaceuticals Corporation
  • 21695-357 Exelon 4.6 mg/24[usp'u] Transdermal Patch, Extended Release by Rebel Distributors Corp
  • 69189-0639 Exelon 3 mg Oral Capsule by Avera Mckennan Hospital

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 54868-5240 QR Code

< Prev: 54868-5239Next: 54868-5241 >

Related Discussions:

Meto tartrate
I started taking Metoprolol Tart 25mg prescribed by the ER..Ever since i started taking it my vision has gotten really b... 2 replies
Zolpidem Tartrate 5 Mg
can I take zolpidem with augmentin 875-125 ## I didn't find any interactions listed between these two medications, b... 4 replies
zolpidem tartrate 10mg side effects
I take half of a 10 mg of Zolpidem to help me sleep. Lately I have been experiencing crawling and itching of the skin. I... 3 replies
metoprol tartrate
generic-for heart & blood pressure ## i have been taking metroprol 50 mg for 3-4 months and am experiencing in the m... 3 replies
zolpidem tartrate 5mg
round, purple, M Z1, tablet ## has anyone seen a zolpidem {or any meds} that are small round purple pill w/M Z1 on one s... 2 replies
zolpiden tartrate 10MG tablet
white oblong pill and onone side it say w517 the other side is blank.ii jst took andthis is to hlep ne seep ## Is it pos... 2 replies
Zolpidem Tartrate Tablets I P
SN 10 on one side of as white oblong scored pill ## Just to confirm, the pill in description is identified as Stilnox, a... 2 replies
zolpidem tartrate 10 mg
Oval shaped Apo on one side white 10 on other side new prescription oblong shaped peach-yellow 5 dots (like #5 dice) and... 2 replies
zolpidem tartrate tablets i p manufactured by zolt
I know exactly what your taking about and they are fine. I suffer from chronic insomnia and could no longer afford to se... 1 reply
zolpidem tartrate
Small oval pill with APO on one side and ZOLS on the other ## The pill in description marked APO ZOL 5, is Zolpidem tart... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.